万维提示：
1、该刊只有国际刊号！
2、投稿方式：在线投稿。
3、官网网址：https://journal.hep.com.cn/lifemed
https://academic.oup.com/lifemedi
4、投稿系统：
https://mc.manuscriptcentral.com/lifemed
5、官网邮箱：Lifemedicine@biscrm.ac.cn
6、官网电话：010-58582187
7、出刊日期：双月刊，逢双月出版。
2024年8月1日星期四
基础医学新刊Life Medicine起航
【微信公众号信息】
Life Medicine Life Medicine 2022-05-08
期刊定位与目标
Life Medicine 是由高等教育出版社（Higher Education Press, HEP）联合牛津大学出版社（Oxford University Press, OUP）共同创办的Life系列期刊群面向基础医学领域推出的旗舰期刊，与Life Metabolism互为姊妹刊。Life Medicine 将为基础医学研究领域的高水平工作提供新的学术家园，为该领域的科研人员和创新成果提供优质交流平台。
Life Medicine 致力于推广改善人类健康的基础研究工作，涵盖与健康和疾病密切相关的机制、预警与干预研究、以及以改善生命健康为目标的新药研发及技术创新成果。
重点领域
Life Medicine 聚焦具有高度创新性和广泛兴趣的人类健康和医学研究，发表与人类健康密切相关的基础医学研究最新成果，包括但不限于健康科学、智能医学、老年医学、再生医学、药理学、遗传疾病、传染疾病、心血管疾病、呼吸疾病、消化疾病、神经疾病和免疫疾病，致力于为医学基础研究及临床转化提供系统的学术创新平台。
期刊栏目
Life Medicine 栏目多样，包括Article、Resource、Review、Letter、Preview、Research Highlight、News & Opinion等。
宣传推广
读者可通过以下平台获取Life Medicine 的最新进展：
官方投稿系统
(https://mc.manuscriptcentral.com/lifemed)
微信公众号 (Life Medicine)
Twitter官方账号 (@LifeMedJournal)
联系邮箱 (包括Presubmission inquiry)（Lifemedicine@biscrm.ac.cn）
Life Medicine 拥有一支具有国际化视野和丰富办刊经验的主编及编委会团队，由数十位来自不同国家的知名生物学家和基础医学家组成，覆盖生物学、基础医学、转化医学和交叉科学等多个领域。
诚邀投稿
Life Medicine 官方投稿系统已正式上线。值此之际，诚挚邀请生命医学及相关交叉领域的科研人员们投稿。
Guidelines for authors投稿指南
【官网信息】
Guidelines for authors
Submission
We will consider your manuscript as long as
it is your own original work and does not duplicate any previously published work, including your own;
it is not under consideration, in peer review, or accepted for publication in any journal other than Life Medicine;
it has not been published in any other journal; and
it contains nothing abusive, defamatory, libelous, obscene, fraudulent, or illegal.
Authors should observe high ethical standards and obey publication best practices. The following are all unacceptable:
data falsification or fabrication
plagiarism, including duplicate publication of your own work without proper citation
misappropriation of work
We treat any case of ethical or publication malpractice very seriously. We will address them in accordance with the Committee on Publication Ethics (COPE) guidelines. Further information about OUP’s ethical policies is available.
How to Submit
You must submit your paper via our web-based submission system. If you have not published with Life Medicine before, you will need to create an account. More information is available on the ScholarOne Manuscripts FAQ and help page. Questions about submitting can be sent to the editorial office at lifemedicine@biscrm.ac.cn
Article Type
This journal publishes several different article types.
Articles—Maximum Word Count: 6,000
abstract—unstructured abstract; maximum word count: 200
keywords—maximum keywords: 5; each keyword can be a maximum of 6 words
references—maximum references: 150
tables and figures—maximum of 8 figures and 6 tables
Each submission must contain the following sections: abstract, keywords, introduction, results, discussion, research limitations, materials and methods, references.
Resources—Maximum Word Count: 6,000
abstract—unstructured abstract; maximum word count: 200
keywords—maximum keywords: 5; each keyword can be a maximum of 6 words
references—maximum references: 150
tables and figures—maximum of 8 figures and 6 tables
Each submission must contain the following sections: abstract, keywords, introduction, results, discussion, research limitations, materials and methods, references.
Reviews—maximum word count: 10,000
abstract—unstructured abstract; maximum word count: 200
keywords—maximum keywords: 5; each keyword can be a maximum of 6 words
references—maximum references: 300
tables and figures—maximum of 8 figures and 6 tables
No structured sections required for Reviews. For invited Reviews to a group of specialists on a given subject, there are no limitations on maximum word count, references, or tables and figures.
Letters—maximum word count 1,500
……
更多详情：
https://journal.hep.com.cn/lifemed/EN/column/column30337.shtml
